Laura Machin Galarza | Pharmacology | Young Scientist Award

Published on by World Top Scientists

Assist. Prof. Dr. Laura Machin Galarza | Pharmacology | Young Scientist Award

Laura Machin Galarza | University of Havana | Cuba

Dr. Laura Machin Galarza is an Assistant Professor and Researcher at the Institute of Pharmacy and Foods, University of Havana, specializing in pharmaceutical sciences and parasitology. She holds a Bachelor’s, Master’s, and Doctorate in Pharmaceutical Sciences from the University of Havana, where her academic journey has been marked by excellence and commitment to translational research. Dr. Machin has undertaken prestigious research stays at institutions in Austria, Germany, China, and Cuba, contributing to international collaborations focused on pharmacology, toxicology, and biopharmaceutical innovation. Her professional experience includes leadership in multidisciplinary projects exploring the antiprotozoal and antileishmanial potential of natural and synthetic compounds, advanced drug delivery systems, and pharmacological recycling strategies. She has authored multiple peer-reviewed publications in high-impact journals such as Pharmaceuticals, Molecules, and Experimental Parasitology, demonstrating expertise in medicinal chemistry and drug development. Dr. Machin’s work has been recognized through contributions to award-winning research honored by the Cuban Academy of Sciences. She actively serves in academic editorial processes, participates in professional scientific societies, and holds certifications that reflect her dedication to research excellence, innovation, and scientific leadership in the field of pharmaceutical sciences.

Profiles: Google Scholar | Scopus 

Featured Publications

1. B. Salehi, L. Machin, L. Monzote, J. Sharifi-Rad, S. M. Ezzat, M. A. Salem, et al., “Therapeutic potential of quercetin: new insights and perspectives for human health,” ACS Omega, vol. 5, no. 20, pp. 11849–11872, 2020.

2. B. Tamargo, L. Monzote, A. Piñón, L. Machín, M. García, R. Scull, W. N. Setzer, “In vitro and in vivo evaluation of essential oil from Artemisia absinthium L. formulated in nanocochleates against cutaneous leishmaniasis,” Medicines, vol. 4, no. 2, p. 38, 2017.

3. L. Machín, R. Nápoles, L. Gille, L. Monzote, “Leishmania amazonensis response to artemisinin and derivatives,” Parasitology International, vol. 80, p. 102218, 2021.

4. G. Geroldinger, M. Tonner, J. Quirgst, M. Walter, S. De Sarkar, L. Machín, et al., “Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: a possible link,” Biochemical Pharmacology, vol. 173, p. 113737, 2020.

5. L. Machín, B. Tamargo, A. Piñón, R. C. Atíes, R. Scull, W. N. Setzer, L. Monzote, “Bixa orellana L. (Bixaceae) and Dysphania ambrosioides (L.) Mosyakin & Clemants (Amaranthaceae) essential oils formulated in nanocochleates against Leishmania amazonensis,” Molecules, vol. 24, no. 23, p. 4222, 2019.

Ksenia Blinova | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Ksenia Blinova | Pharmacology | Best Researcher Award

Associate Director at US Food and Drug Administration, United States

Dr. Ksenia Blinova, Ph.D., is the Associate Director for the Division of Applied Regulatory Science at the U.S. Food and Drug Administration, where she leads innovative research, regulatory reviews, and scientific consultations that advance translational science in support of public health. With a strong academic foundation in physics, mathematics, and cardiac electrophysiology, she has built a distinguished career focused on bridging fundamental science with regulatory applications. Since joining the FDA as a Commissioner’s Fellow, Dr. Blinova has held key leadership roles, including Deputy Director of the Division of Biomedical Physics, where she led multidisciplinary teams in developing over forty regulatory science tools that improved the evaluation of medical devices across fields such as cardiology, neurostimulation, diagnostics, and patient monitoring. Her career reflects a unique combination of scientific excellence, leadership, and commitment to advancing safe and effective medical products, making her an influential figure in the field of regulatory science.

Professional Profile 

Scopus Profile | ORCID Profile 

Education

Dr. Ksenia Blinova earned her undergraduate and doctoral degrees in Physics and Mathematics from Moscow State University, where she developed a strong foundation in quantitative sciences and analytical problem-solving. She further advanced her academic journey through a postdoctoral fellowship at the National Heart, Lung, and Blood Institute at the National Institutes of Health. Her research during this period centered on cardiac electrophysiology and metabolism, areas that deepened her expertise in biomedical applications of physical sciences. This educational trajectory not only equipped her with advanced technical knowledge but also gave her a unique interdisciplinary perspective that integrates rigorous physics and mathematical methodologies with life sciences and clinical research. Her educational background has been pivotal in shaping her ability to address complex regulatory and scientific challenges, contributing to her capacity for innovation and leadership in translational science and regulatory policy at the intersection of medicine, technology, and public health.

Experience

Dr. Blinova has built a distinguished career at the U.S. Food and Drug Administration, beginning as a Commissioner’s Fellow and progressing to influential leadership roles. As Deputy Director of the Division of Biomedical Physics in the Center for Devices and Radiological Health, she guided a multidisciplinary team in creating innovative regulatory science tools that addressed critical challenges in medical device safety and effectiveness. Her leadership was instrumental in developing methods and resources for fields such as cardiology, neurostimulation, ophthalmology, in-vivo diagnostics, and advanced patient monitoring. Currently serving as Associate Director for the Division of Applied Regulatory Science in the Office of Clinical Pharmacology, she oversees research, scientific consultations, and regulatory reviews that support the FDA’s translational science priorities. Through these roles, she has combined her technical expertise with strategic vision, ensuring that scientific advancements translate into practical regulatory applications that safeguard patient health and promote medical innovation.

Research Focus

Dr. Blinova’s research focuses on advancing translational and regulatory science to accelerate the safe and effective delivery of medical products to patients. Her early work in cardiac electrophysiology and metabolism provided insights into fundamental mechanisms of heart function, laying the groundwork for her later contributions in biomedical physics and device evaluation. At the FDA, she has led research efforts that integrate computational modeling, experimental studies, and regulatory tool development to address complex safety and efficacy challenges in medical devices and drug-device combinations. Her team has developed innovative approaches to evaluate technologies in cardiology, neurostimulation, electrical safety, diagnostics, and patient monitoring, ensuring that regulatory science keeps pace with rapid technological advances. By bridging basic science, applied research, and policy, her work exemplifies the role of regulatory science in translating innovation into tangible benefits for patients and healthcare systems, while maintaining a focus on safety, effectiveness, and public health impact.

Award and Honor

Throughout her career, Dr. Blinova has been recognized for her leadership, innovation, and contributions to regulatory science. Her accomplishments include guiding the development of over forty regulatory tools that have had a lasting impact on how medical devices are assessed for safety and effectiveness. These achievements reflect not only her scientific expertise but also her ability to collaborate across disciplines to solve pressing healthcare challenges. Her recognition within the FDA and broader scientific community underscores her role as a leader who consistently advances the field of translational science. Honors and awards in her career highlight her success in bridging science and regulation, her dedication to patient safety, and her influence in shaping modern approaches to medical product evaluation. These distinctions serve as a testament to her sustained contributions, her commitment to innovation, and her growing impact as a respected figure in regulatory and biomedical research.

Publication Top Notes

  • Title: Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential
    Authors: M. Iveth Garcia, Bhavya Bhardwaj, Keri Dame, Verena Charwat, Brian A. Siemons, Ishan Goswami, Omnia A. Ismaiel, Sabyasachy Mistry, Tromondae K. Feaster, Kevin E. Healy, et al.
    Year: 2025

  • Title: In Vitro Assay Development to Study Pulse Field Ablation Outcome Using Solanum Tuberosum
    Authors: Akshay Narkar, Abouzar Kaboudian, Yasaman Ardeshirpour, Maura Casciola, Tromondae Feaster, Ksenia Blinova
    Year: 2024
    Citations: 2

  • Title: Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues
    Authors: Tromondae K. Feaster, Jourdan K. Ewoldt, Anna Avila, Maura Casciola, Akshay Narkar, Christopher S. Chen, Ksenia Blinova
    Year: 2024

  • Title: Comprehensive Collection of Current Methods for Contractility and Electrophysiology Recordings in Human Cardiac Cells
    Authors: Ksenia Blinova, J. Pierson, A. Narkar
    Year: 2023

  • Title: Human in vitro assay for irreversible electroporation cardiac ablation
    Authors: Maura Casciola, Tromondae K. Feaster, M. J. Caiola, D. Keck, Ksenia Blinova
    Year: 2023

  • Title: Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
    Authors: Tromondae K. Feaster, N. Feric, I. Pallotta, A. Narkar, M. Casciola, M. P. Graziano, R. Aschar-Sobbi, Ksenia Blinova
    Year: 2022

  • Title: Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2022

  • Title: Human in vitro neurocardiac coculture (iv NCC) assay development for evaluating cardiac contractility modulation
    Authors: Akshay Narkar, Tromondae K. Feaster, Maura Casciola, Ksenia Blinova
    Year: 2022

  • Title: Human cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells
    Authors: Maura Casciola, Devin Keck, Tromondae K. Feaster, Ksenia Blinova
    Year: 2022

  • Title: Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
    Authors: Akshay Narkar, James M. Willard, Ksenia Blinova
    Year: 2022

  • Title: Cardiovascular medical devices: Regulatory science research overview in the office of science and engineering laboratories (OSEL) at the food and drug administration (FDA)
    Authors: K. Aycock, Ksenia Blinova, M. Casciola, B. Craven, M. Di Prima, G. D’Souza, N. Duraiswamy, M. Farahmand, P. Hariharan, L. Herbertson, et al.
    Year: 2021

  • Title: Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2021

Conclusion

Dr. Ksenia Blinova has demonstrated exceptional expertise and leadership in translational and regulatory science, particularly in the evaluation and development of cardiac therapies and medical devices. Her extensive body of research, including numerous high-impact publications on human in vitro cardiac models, contractility modulation, and electroporation assays, reflects a consistent focus on innovative approaches that bridge fundamental science with practical clinical and regulatory applications. She has led multidisciplinary teams to develop tools and methodologies that enhance patient safety, accelerate medical innovation, and provide reliable scientific evidence for regulatory decisions. Her work not only advances the understanding of cardiac electrophysiology and device performance but also sets new standards for predictive, nonclinical cardiac research. Overall, Dr. Blinova’s contributions exemplify the qualities of a pioneering researcher whose scientific rigor, leadership, and commitment to public health make her highly deserving of recognition in any Best Researcher Award.

Lichun Zhao | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Lichun Zhao | Pharmacology | Best Researcher Award

Guizhou University of Traditional Chinese Medicine, China

Prof. Dr. Lichun Zhao is a distinguished researcher and academic leader specializing in trace elements, traditional medicine, and health development. He serves as a doctoral supervisor, director of research centers and laboratories, and executive editor in chief of Trace Elements and Health Research, while holding key leadership roles in national and regional scientific associations. Recognized with numerous prestigious honors, he has successfully led major national and international projects, secured innovative medicine approvals, and contributed to product development. His prolific output includes over two hundred publications, highly cited SCI papers, multiple monographs, patents, and software copyrights, reflecting both scientific innovation and practical application. He has also been honored with multiple science and technology awards, underscoring the impact of his research. Committed to advancing both scholarship and healthcare, Prof. Zhao exemplifies excellence in integrating academic research, innovation, and leadership, making him a highly influential figure in his field.

Professional Profile 

Scopus Profile

Education

Prof. Dr. Lichun Zhao earned his Ph.D. in a field closely related to trace elements, medicine, and health sciences, building a solid academic foundation for his future research. Following his doctoral studies, he pursued postdoctoral training at Hong Kong Baptist University, where he broadened his expertise and gained valuable international research exposure. His educational journey reflects a strong emphasis on both traditional medicine and modern scientific approaches, allowing him to bridge classical knowledge with contemporary methodologies. By combining advanced laboratory techniques with deep understanding of traditional Chinese medicine, he has cultivated a unique academic profile that continues to drive his research innovations. His educational background not only prepared him for his roles in academia and research but also established his credentials as a mentor for doctoral students and an authoritative voice in integrating traditional practices with modern scientific frameworks.

Experience

Prof. Dr. Zhao has accumulated extensive academic and professional experience through his multiple leadership roles and active engagement in research. He serves as a doctoral supervisor, guiding and mentoring the next generation of researchers, while simultaneously holding positions as director of the Research Department and the Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. Beyond his university roles, he directs major laboratories in Guizhou and Guangxi, leading innovation in endangered medicinal resources. His editorial work as executive editor in chief of Trace Elements and Health Research further demonstrates his commitment to advancing scholarly communication. In addition, he actively contributes to national scientific development as a project evaluation expert for significant research foundations and technology awards. Through these experiences, Prof. Zhao has built a career that integrates research, leadership, and service, positioning him as both a pioneering scientist and an influential academic administrator.

Research Focus

The core of Prof. Dr. Zhao’s research lies in the intersection of trace elements, traditional Chinese medicine, and health development. His work emphasizes the exploration of medicinal resources, the development of innovative treatments, and the application of modern scientific tools such as big data and artificial intelligence to healthcare research. He has led numerous national and international projects aimed at advancing understanding of trace elements in human health, as well as developing standardized, evidence-based approaches to traditional medicine. A significant part of his focus is dedicated to the preservation and innovation of endangered medicinal materials, ensuring sustainable resources for future therapeutic use. His achievements include obtaining clinical approvals for new medicine, producing certified products, and publishing influential studies recognized globally. Prof. Zhao’s research is notable for its ability to combine ancient knowledge with modern technology, creating novel solutions that enhance healthcare outcomes and scientific advancement.

Award and Honor

Prof. Dr. Zhao has been widely recognized for his scientific excellence and leadership with numerous national and regional awards. He was the first to receive the prestigious National Youth Qihuang Scholar distinction and has been selected for Hong Kong’s “Excellent Talent Plan.” His honors include recognition as an Outstanding Scholar in Guangxi, a leader of high-level innovation teams, and a candidate in talent development initiatives such as the “Ten Hundred Thousand Talents Project.” He has also received the Guangxi Youth Science and Technology Award and multiple provincial science and technology prizes, including the Guangxi Science and Technology Progress Award and the Jilin Province Natural Science Award. His contributions have further been acknowledged through the China Industry-University-Research Cooperation Innovation Award. Collectively, these distinctions highlight not only his research excellence but also his role as an innovator and leader whose work has had profound impact in both academic and applied scientific fields.

Publications Top Notes

  • Title: The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Bacteriostatic activity and mechanism of minerals containing rubidium
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
    Authors: Zhao Lichun et al.
    Year: 2025
    Citations: 3

  • Title: Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
    Authors: Zhao Lichun et al.
    Year: 2025
    Citations: 13

  • Title: Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
    Authors: Zhao Lichun et al.
    Year: 2024
    Citations: 22

Conclusion

The reviewed publications of Prof. Dr. Lichun Zhao reflect a strong and diverse research portfolio spanning trace elements, traditional Chinese medicine, cancer biology, inflammatory diseases, and innovative material science applications. His works demonstrate both depth in exploring mechanisms of disease and breadth in applying interdisciplinary approaches to health solutions. The range of topics covered—from Alzheimer’s disease and rhinosinusitis to breast cancer and ulcerative colitis—highlights his ability to integrate traditional medicine knowledge with modern biomedical and technological advances. The citations already received for some of these recent studies, particularly in high-impact areas such as cancer research and therapeutic innovations, indicate growing recognition of his contributions within the scientific community. Overall, his research achievements showcase academic rigor, innovation, and practical significance, further strengthening his candidacy for recognition through prestigious research awards.

Mojtaba Ajorloo | Waste Recycling | Best Researcher Award

Published on by World Top Scientists

Mr.  Mojtaba Ajorloo | Waste Recycling | Best Researcher Award

Mojtaba Ajorloo, UNSW, Australia

Mojtaba Ajorloo is a dedicated individual currently residing in Sydney, NSW. He is associated with UNSW, showcasing his commitment to academic pursuits and professional growth in Australia. With a passion for advancing knowledge, Mojtaba stands out as a promising figure in the academic realm. His contact details include a phone number: +61452572417, and email: mj.ajorloo7@gmail.com. As an active member of the UNSW community, Mojtaba contributes to the academic landscape with enthusiasm and determination. 🌏✨

Profile

linkedin

Google Scholar

Education 

Currently, Mojtaba is on an academic journey at the University of New South Wales (UNSW), Sydney, Australia, where he is pursuing a Ph.D. in Chemical-Mechanical Engineering with a specialization in Waste-to-Energy. His commitment to exploring innovative solutions for waste management and energy production demonstrates his dedication to sustainable practices. Mojtaba’s academic pursuits, spanning across renowned institutions in Iran and Australia, underscore his passion for advancing the field of Chemical Engineering. 🎓🌍🔬

Skills

Meet Jane, a dynamic professional with a proven track record in project management. 🚀 Armed with exceptional time management skills, she navigates complex tasks effortlessly, ensuring projects are delivered on schedule. Her robust technical expertise and adeptness in analytical report writing showcase a keen eye for detail and a commitment to excellence. Jane is well-versed in technical and project management standards, demonstrating a dedication to quality and precision in every endeavor. As a team leader, she fosters collaboration and teamwork, driving collective success.

Research Experiences

Meet Mojtaba Ajorloo, a diligent researcher with a passion for sustainability and innovation. 🌱 With a Ph.D. project focused on thermodynamic analysis of waste-to-energy processes at UNSW, Sydney, they’ve showcased expertise in both literature review and experimental design, resulting in published articles and validated thermodynamic models. As a research assistant on industry-funded projects, they’ve excelled in designing experiments, optimizing processes, and meeting rigorous standards, such as ASTM requirements for automotive applications. Their collaborative spirit, technical acumen, and dedication to environmentally conscious solutions make them a valuable asset to any research team. 📚🔬

Publications Top Notes

  1. “How are the thermal properties of polypropylene/graphene nanoplatelet composites affected by polymer chain configuration and size of nanofiller?”
    • Cited by: 69
    • Year: 2019
  2. “Recent advances in thermodynamic analysis of biomass gasification: a review on numerical modeling and simulation”
    • Cited by: 48
    • Year: 2022
  3. “Incorporation of recycled polypropylene and fly ash in polypropylene-based composites for automotive applications”
    • Cited by: 39
    • Year: 2021
  4. “The role of nanofiller size and polymer chain configuration on the properties of polypropylene/graphite nanoplates composites”
    • Cited by: 18
    • Year: 2020
  5. “Modelling and statistical analysis of plastic biomass mixture co-gasification”
    • Cited by: 17
    • Year: 2022
  6. “Heavy metals removal/stabilization from municipal solid waste incineration fly ash: a review and recent trends”
    • Cited by: 16
    • Year: 2022
  7. “A statistical approach to investigate the effects of multicomponent fractions on the mechanical properties of PP/PPMA/Talc/POE composites”
    • Cited by: 9
    • Year: 2020
  8. “Development of a bubble growth model for natural rubber‐based foams”
    • Cited by: 6
    • Year: 2021
  9. “One-step regulating the microstructure in physical foaming process of polypropylene”
    • Cited by: 4
    • Year: 2020
  10. “Modelling and Statistical Analysis of Plastic Steam Gasification”
    • Year: 2022
  11. “Evaluation of the Usage of Recycled Polypropylene and Fly Ash in Modified Polypropylene-Based Composites Used in Automotive Industry”
    • Year: 2019

 

Kumud Bala | Pharmacology | Outstanding Scientist Award

Published on by World Top Scientists

Prof Dr. Kumud Bala | Pharmacology | Outstanding Scientist Award

Professor, Amity Institute of Biotechnology, India

Dr. Kumud Bala is a distinguished academician and currently serves as the Professor and Deputy Dean of Student Welfare at Amity University. 🎓 With a residence at 703 BSES Housing Association, B Block, Plot No-9/17, Sector 62, NOIDA, UP 201 301, Dr. Bala is deeply committed to the well-being and development of students. 🏫 She brings a wealth of knowledge and experience to her role, contributing significantly to the academic community. Dr. Kumud Bala’s contact details include her residential phone number (120) 433 2136 and mobile contact at 98112 92212. 📞 Additionally, she can be reached via email at kumud.bala.singh@gmail.com and kbala@amity.edu. 📧

Profile

scopus

Educational Credentials 

Dr. Kumud Bala embarked on her academic journey in 1992, earning a B.Sc. in Zoology from Patna University with distinction, securing 71%. 🎓 She continued her pursuit of knowledge, attaining an M.Sc. in Immunology in 1995 with an impressive 65% from the same university. 🧪

In 1996, she cleared the B.E.T. (Eligibility for lectureship exam) in Zoology, demonstrating her commitment to academia and qualifying under the UGC. 📚 Subsequently, in 1999, Dr. Bala successfully navigated the Research Entrance Test (R.E.T.), a pivotal step leading to her Ph.D. journey in Biotechnology. 🧬

The culmination of her academic endeavors came in 2003 when she was awarded a Ph.D. from Patna University. Her doctoral thesis, titled “Mimosa Pudica and Vinca Rosea Extracts to Reduce Pesticide Induced Toxicity in Bone Marrow and Blood of Mice,” showcased her expertise in biotechnology and dedication to addressing environmental challenges. 🌱

Awards Received

Dr. Kumud Bala’s academic journey is adorned with prestigious recognitions and scholarships. From July 1986 to March 1992, she was a recipient of the Special State Merit Scholarship, a commendable achievement spanning her studies in I Sc., B.Sc., and M.Sc. 🎓 This scholarship reflects her consistent excellence and dedication to her academic pursuits during those years. Subsequently, from April 1999 to March 2003, Dr. Bala was awarded the Teacher’s Fellowship by the UGC, Government of India, supporting her in her pursuit of a Ph.D. 📚 This fellowship is a testament to her scholarly endeavors and commitment to advancing knowledge in her field. In recognition of her contributions, she received the Award of Excellence from AIIMS, New Delhi, and PGIMER, Chandigarh, during the period of October 25th to 30th, 2010. 🏆 Her responsibilities included organizing the 10th INPALMS at Amity University, Noida, U.P., showcasing her leadership and organizational skills. These awards and scholarships underscore Dr. Kumud Bala’s commitment to academic excellence, research, and her significant contributions to the field. 🌈

Career Highlights

Since November 1996, Dr. Kumud Bala has been an unwavering force in academia. As a Lecturer at the Department of Zoology, St. Columba’s College, Hazaribagh, she adeptly taught undergraduates and postgraduates in Immunology, Cell and Molecular Biology, Genetics, and Pharmaceutical Biotechnology. 📚 Her tenure at Amity University since June 2007 has seen her excel in guiding over 50 students in diverse projects, from Animal Model Development to Drug Targeting through Molecular Modeling. 🌟 Dr. Bala’s dedication extends beyond teaching, encompassing student motivation, career development, and holistic skill enhancement. 💡

Computer and Technique Proficiency 

Dr. Kumud Bala seamlessly integrates technology into her professional toolkit, boasting a proficient command of Windows, MS-Office, Internet navigation, HTML, MS Excel, and SPSS. 🖥️ Her adeptness extends further, having completed a Diploma in Advanced Computer Application from NIIT, Patna in 1999, solidifying her tech-savvy credentials. 🎓 This comprehensive skill set empowers her to navigate the digital landscape with ease, enhancing her efficiency in both academic and administrative domains. 💻

Publications Top Notes

📚 1. Exploring TLR signaling pathways as promising targets in cervical cancer: the road less traveled

👨‍💼 Authors: Agarwal, M., Kumar, M., Pathak, R., Bala, K., Kumar, A.

📅 Year: 2024

📖 Journal: International Review of Cell and Molecular Biology

📚 2. Author Correction: Novel biogenic silver nanoconjugates of Abrus precatorius seed extracts and their antiproliferative and antiangiogenic efficacies

👨‍💼 Authors: Kaur, A., Sharma, Y., Singh, G., … Khan, A.A., Bala, K.

📅 Year: 2023

📖 Journal: Scientific Reports

🔗 DOI: 10.1038/s41598-023-40079-8

 

📚 3. Novel biogenic silver nanoconjugates of Abrus precatorius seed extracts and their antiproliferative and antiangiogenic efficacies

👨‍💼 Authors: Kaur, A., Sharma, Y., Singh, G., … Khan, A.A., Bala, K.

📅 Year: 2023

📖 Journal: Scientific Reports

🔗 DOI: 10.1038/s41598-023-40079-8

🔗 Citation:  1

📚 4. Effective seed cake extract of O. sanctum inducing the p53 dependent apoptotic pathway in oral cancer cells

👨‍💼 Authors: Sharma, Y., Mishra, R., Kaur, A., Bharadwaj, M., Bala, K.

📅 Year: 2023

📖 Journal: Drug Development and Industrial Pharmacy

📚 5. Assessing the potential of rosary pea (Abrus precatorius L.) derived aqueous seed extracts as anticancer agents and their phytoconstituents as COX-2 inhibitor: an in-vitro and in-silico approach

👨‍💼 Authors: Kaur, A., Singh, G., Sharma, Y., … Kumar, A., Bala, K.

📅 Year: 2023

📖 Journal: Journal of Biomolecular Structure and Dynamics

🔗 DOI: Not available

📚 6. Antiproliferative efficacy of the antioxidant bioactive compounds of defatted seeds of Azadirachta indica and Momordica charantia against the regulatory function of tumor suppressor gene inducing oral carcinoma

👨‍💼 Authors: Sharma, Y., Kaur, A., Mishra, R., … Bharadwaj, M., Bala, K.

📅 Year: 2023

📖 Journal: Journal of Biomolecular Structure and Dynamics

🔗 DOI: Not available

📚 7. In-vitro antiproliferative efficacy of Abrus precatorius seed extracts on cervical carcinoma

👨‍💼 Authors: Kaur, A., Sharma, Y., Kumar, A., Ghosh, M.P., Bala, K.

📅 Year: 2022

📖 Journal: Scientific Reports

🔗 DOI: 10.1038/s41598-022-04122-7

📚 8. METABOLITES OF ABRUS PRECATORIUS TARGETING MULTIPLE ONCOGENIC AND ONCO-SUPPRESSIVE SIGNALING FOR CANCER PREVENTION AND INTERVENTION

👨‍💼 Authors: Kaur, A., Sharma, Y., Kumar, A., Bala, K.

📅 Year: 2022

📖 Journal: Journal of Microbiology, Biotechnology and Food Sciences

🔗 DOI: 10.15414/jmbfs.2022.12.2.22-28

📚 9. Preclinical assessment of stem of Nicotiana tabacum on excision wound model

👨‍💼 Authors: Sharma, Y., Kaur, A., Bhardwaj, R., … Madan, S., Bala, K.

📅 Year: 2021

📖 Journal: Bioorganic Chemistry

🔗 DOI: 10.1016/j.bioorg.2021.104731

📚 10. Antioxidant and antimicrobial activity of protein-agnps from the stem of nicotiana tabacum

👨‍💼 Authors: Sharma, Y., Srivastava, N., Bala, K.

📅 Year: 2021

📖 Journal: Current Bioactive Compounds

🔗 DOI: 10.2174/1573407217999200713101603